Pure Global
NCT05763771

Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study

M.D. Anderson Cancer Center·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Smart Phone App
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
M.D. Anderson Cancer Center
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 31, 2023
End date
Dec 01, 2026
Enrollment
75 participants
Primary outcome

Application (App) Usability Questionnaire

Summary

To collect user experience data for a smartphone app that is designed to help people reduce
 or quit smoking and to learn if the app, combined with nicotine patches, can help people quit
 smoking.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05763771
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05763771 through Pure Global AI's free database. This phase not specified trial is sponsored by M.D. Anderson Cancer Center and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.